Lupin acquires VISUfarma to enhance ophthalmology offerings
after close1 source ↓written by the desknot a recommendation
- portfolio
- 60 branded products
Lupin Limited has completed the acquisition of VISUfarma B.V. from GHO Capital Partners LLP, expanding its ophthalmology portfolio to over 60 branded products. This move strengthens Lupin's presence in key European markets, including Italy, UK, Spain, Germany, and France. The acquisition aligns with rising global demand for eye care, enhancing Lupin's specialty care capabilities.
Not investment advice. For informational purposes only.